Comparing AlloDerm and DermACELL in Breast Reconstruction

Completed · Not applicable

Conditions studied: Acellular Dermal Matrix in Breast Reconstruction

In brief

This study will compare 90-day complication rates between breasts reconstructed with tissue expanders and AlloDerm vs. DermACELL, with each patient serving as her own comparator.

Key facts

Study ID

NCT04710537

Run by

Johns Hopkins University

People needed

50

Starts

2021-10-21

Expected to finish

2022-07-26

Last updated by the study team

2022-08-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients over the age of 18
• May be undergoing either therapeutic or prophylactic mastectomy
• Must be undergoing bilateral mastectomy and breast reconstruction with tissue expanders

You may not qualify if…

• Patients who wish to avoid the use of ADM in their reconstruction
• History of radiation of the breast
• Unilateral mastectomies
• Direct to implant breast reconstruction (not utilizing a tissue expander)

Where it is running

• DAVinci Plastic Surgery — Washington D.C., District of Columbia, United States
• Sibley Memorial Hospital — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.